Emedastine difumarate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H26N4O.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42MB94QOSM, chemically known as 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1h-1,4-diazepin-1-yl)benzimidazole fumarate (1:2), but more generally known as emedastine difumarate, which bears US NIH Compound Identifier 5282485. European Medicines Agency schedules emedastine difumarate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06503MIG. Most nations, for tariff purposes, schedule emedastine difumarate under HS 29339940. As of Q4 2014, EMEDASTINE DIFUMARATE remains US FDA's Preferred Term for this commodity. Emedastine difumarate bears US NLM identifiers UMLS ID C0724578 and NCI Concept Code C61744. SMILES: CCOCCN1C(NC2C1CCCC2)N3CCN(CCC3)C.C(=C/C(=O)O)\C(=O)O.C(=C/C(=O)O)\C(=O)O.